Ajanta Pharma Limited — Important, 20-03-2025: Capacity addition

Ajanta Pharma has announced a board meeting on capacity expansion, adding a new liquid formulation facility at its Pithampur site. This enhancement will increase production capacity from 6 million to 18 million bottles per annum, with an investment of ₹92 crore financed through internal accruals. The expansion aims to address rising global demand for their liquid formulations, projected to be operational by Q1 FY 2026.

This strategic move is likely to bolster the company’s market position, offering significant growth potential and improving financial performance. Investors may view this development positively, aligning with increasing consumer demand and potential revenue growth.